Metabolic syndrome. Metabolic syndrome
Conditions
Interventions
Intervention 1: Intervention group: Subjects in the intervention group receive Barberry capsules (daily intake of 600 mg) for 6 weeks (n=53). The participants take one capsule every day, which was con
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 18–65 years old Patients with Metabolic Syndrome according to the International Diabetic Federation criteria
Exclusion criteria
Exclusion criteria: Systemic diseases such as lupus, kidney disease, acquired immunodeficiency syndrome and rheumatoid arthritis Pregnant and lactating women Drug usage including consumption of the lipid-lowering, antihypertensive and antidiabetic drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anti-Heat Shock Protein titre. Timepoint: Before the intervention and 6 weeks after taking drug or placebo. Method of measurement: Enzyme Linked Immunosorbent Assay.;Pro-Oxidant–Antioxidant Balance. Timepoint: Before the intervention and 6 weeks after taking drug or placebo. Method of measurement: Enzyme Linked Immunosorbent Assay.;Superoxide Dismutase. Timepoint: Before the intervention and 6 weeks after taking drug or placebo. Method of measurement: Spectrophotometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Copper. Timepoint: Before the intervention and 6 weeks after taking drug or placebo. Method of measurement: Atomic Absorption.;Serum Zinc. Timepoint: Before the intervention and 6 weeks after taking drug or placebo. Method of measurement: Atomic Absorption. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Ghayour Mobarhan
Mashhad University of Medical Sciences
Outcome results
None listed